ETF Managers Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$717K Sell
17,580
-34,977
-67% -$1.51M 0.02% 320
2022
Q4
$2.69M Buy
52,557
+35,389
+206% +$1.7M 0.13% 94
2022
Q3
$752K Buy
17,168
+1,013
+6% +$49.2K 0.02% 251
2022
Q2
$823K Sell
16,155
-13,375
-45% -$682K 0.02% 255
2022
Q1
$1.55M Buy
29,530
+3,269
+12% +$170K 0.03% 233
2021
Q4
$1.53M Sell
26,261
-2,672
-9% -$132K 0.03% 233
2021
Q3
$1.26M Buy
28,933
+3,109
+12% +$138K 0.02% 246
2021
Q2
$1.01M Sell
25,824
-46,425
-64% -$1.81M 0.02% 274
2021
Q1
$2.61M Sell
72,249
-21,068
-23% -$748K 0.05% 167
2020
Q4
$3.43M Buy
93,317
+58,399
+167% +$2.14M 0.08% 144
2020
Q3
$1.2M Sell
34,918
-11,278
-24% -$395K 0.04% 190
2020
Q2
$1.43M Buy
46,196
+17,061
+59% +$580K 0.05% 154
2020
Q1
$903K Buy
29,135
+22,923
+369% +$781K 0.04% 163
2019
Q4
$229K Buy
6,212
+1,429
+30% +$50.9K 0.01% 502
2019
Q3
$164K Buy
4,783
+103
+2% +$3.75K 0.01% 496
2019
Q2
$193K Buy
+4,680
New +$186K 0.01% 425
2018
Q2
Sell
-2,194
Closed -$73K 570
2018
Q1
$73K Buy
2,194
+274
+14% +$9.42K ﹤0.01% 419
2017
Q4
$66K Buy
1,920
+274
+17% +$9.34K ﹤0.01% 427
2017
Q3
$56K Buy
1,646
+145
+10% +$4.66K ﹤0.01% 332
2017
Q2
$48K Buy
+1,501
New +$47.3K ﹤0.01% 437

Other funds holding PFE

ETF Managers Group's PFE Position: Q1 2023 in Review

ETF Managers Group reduced its Pfizer (PFE) stake by 67% in Q1 2023, selling an estimated $1.51M and leaving 17,580 shares worth $717K. The position accounts for 0.02% of the portfolio, ranked #320.

ETF Managers Group first reported a position in PFE in Q2 2017 and has held it in 20 quarters since. The position peaked at $3.43M in Q4 2020. 3,105 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • ETF Managers Group held 17,580 shares of Pfizer worth $717K as of Q1 2023.
  • ETF Managers Group sold 34,977 Pfizer shares in Q1 2023, an estimated $1.51M.
  • Pfizer made up 0.02% of ETF Managers Group's portfolio in Q1 2023, its #320 holding.
  • ETF Managers Group first reported a position in Pfizer in Q2 2017 and has held it in 20 quarters since.
  • ETF Managers Group's Pfizer position peaked at $3.43M in Q4 2020.
  • 3,105 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.